ArticleFrontiers in oncology2023

Kisspeptin-mediated improvement of sensitivity to BRAF inhibitors in vemurafenib-resistant melanoma cells.

Carlotta Guzzetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.